Tuberculosis in Children Jeffrey R. Starke, MD October 9, 2008

Size: px
Start display at page:

Download "Tuberculosis in Children Jeffrey R. Starke, MD October 9, 2008"

Transcription

1 TB Nurse Case Management Norman, Oklahoma October 810, 2008 Tuberculosis in Children Jeffrey R. Starke, MD October 9, 2008 TUBERCULOSIS IN CHILDREN Jeffrey R. Starke, M.D. Professor and Vice Chairman of Pediatrics Baylor College of Medicine Houston, Texas USA 1

2 Tuberculosis is a social disease with medical implications. A Difficult Case A 7 yo HIV + girl has cough, abdominal pain, cervical and axillary adenopathy, bilateral rales and a large liver. A 10 day course of clarithromycin did not improve her symptoms. Her CD4 count was 291/20%, her hemoglobin was 8.9, but other labs were WNL. After several weeks, her cough improved, she was sweating a lot but did not have fever or weight loss. Her adult cousin had pulmonary tuberculosis 232 years ago [household contact]. Does she have tuberculosis? 2

3 Estimated TB incidence rates, 2000 Rate per or more No estimate The boundaries and names shown and the des ignat i ons used on this map do not imply the express i on of any opinion whatsoever on the part of the World Health Organizat i on concerning the l egal status of any country, territory, c i ty or area or of its authorit ies, or concerning the del im itat i on of its front i ers or boundaries. Dotted l i nes on maps represent approx imate border l ines for which there may not yet be ful l agreement. Global Tuberculos i s Control. WHO Report WHO/CDS/TB/

4 EPIDEMIOLOGY OF TUBERCULOSIS IN THE WORLD WHO ESTIMATES 9.2 million incident cases in million of these cases were sputum AFB smear positive 14.4 million prevalent cases 0.7 million HIVinfected persons with new onset TB in million new cases of multidrug resistant TB in million deaths a/w TB in 2006 Country EPIDEMIOLOGY OF CHILDHOOD TUBERCULOSIS IN SELECTED 22 HIGH BURDEN COUNTRIES Childhood Cases Case Rate % Total Cases Children Total Afghanistan Brazil 23, China 86, Pakistan 61, South Africa 35, Zimbabwe 12, Range Total 659,

5 TRANSITIONS IN TUBERCULOSIS Susceptible Exposed Infected Diseased Sick Diagnosed Treated Cured TIME TABLE OF CHILDHOOD TUBERCULOSIS Site of Disease Miliary and meningeal Time to Develop 199 months Primary pulmonary 2122 months Lymph node [cervical] 2122 months Pleural effusion Skeletal Renal 399 months 6 months 2 years 155 years 5

6 ARE CHILDREN WITH TUBERCULOSIS EVER CONTAGIOUS? Difficult to answer in the community Orphanages caretaker with TB led to transmission; a child with TB did not Schools only 2 reported epidemics caused by children <13 years old Children s s Hospitals rare case reports of transmission, all with special circumstances, none has been patient to patient 6

7 FEATURES OF CONTAGIOUS PEDIATRIC TUBERCULOSIS Cavitary lung lesion Sputum production Positive acidfast stain of sputum smear Bronchoscopy Draining lesions or surgical drainage of an abscess DIAGNOSIS OF TUBERCULOSIS All existing diagnostic tests for TB in children have significant shortcomings Most tests are not available in settings where the vast majority of TB cases are diagnosed The utility of most tests is further diminished in children with immune compromise [especially HIV infection] 7

8 DIAGNOSTIC TESTS FOR CHILDHOOD TUBERCULOSIS The sensitivity and specificity of the available tests are inherent in the tests However, the positive and negative predictive values are inherent in the population on whom the tests are used Therefore, all tests are more accurate when used on children with a high index of suspicion [epidemiology HISTORY OF RECENT CONTACT TO A TB CASE or suspicious symptoms] Sensitivity = Specificity = 95% 90% prevalence 1% prevalence PPV= 99% (1% false+) PPV=15% (85% false+) 8

9 MANTOUX TUBERCULIN SKIN TEST uses 5 TU [2 TU if R23] of purified protein derivative interpret in hours record size of induration in mm if it makes a reaction at >72 hrs, it counts! false negatives: 10% to 20% in disease FACTORS S THAT CAUSE DECREASED RESPONSE TO TUBERCULIN Hostre related Infection ions,, vaccinev accines Chronic disease, malnutrm lnutritiontion Immunosuppressive diseases (HIV, malignancy, CVD) Drugs (corti ticosteroids) Extremes es of o age, stresss Over erwhelming tuberculo ulosis Tuberculin related Improper storage or diluti tion Adsorption to glass or o plastic Administra ration relat lated Reading rela lated 9

10 INDURATION SIZE POSITIVE TUBERCULIN N SKIN TEST > 5 mm > 10 mm HIV coin infection Foreignborn from a HR country Immune compromisec Drug users Recent contact to TB Living in HR congregate Suspected ed disease setting Specific HR groups Children < 4 yrs y s old (AAP) > 15 mm No risk factors Previous BCG G vaccination? 10

11 INTERACTION OF BCG VACCINES WITH THE TUBERCULIN SKIN TEST 50% of vaccinated infants do not react to a TST; most of the rest stop reacting within 5 years most noninfants who get one or more BCG vaccinations will react to a TST (usually < 15 mm), but effect wanes over 5 10 years outside infancy, positive TST more likely to indicate infection with M. tuberculosis than be residual from BCG TUBERCULINN SKIN TESTING OF FOREIGNBORN ADOPTEES On one hand, most children have received a BCG vaccine within the past year, which can cause reaction to a TST On the other hand, many have lived in conditions conducive to transmission of M. tuberculosis and we can t t do an investigation 11

12 TUBERCULINN SKIN TESTING OF FOREIGNBORN ADOPTEES General Guidelines 1. Assess for symptoms of tuberculosis disease prolonged (>2 wk) cough, weight loss, fevers 2. Note a BCG scar and/or immunization records 3. Place and read a 5 TU TST without controls 4. Delay or repeat the TST if the child is significantly malnourished 5. Positive TST reaction is 10mm, though this will result in some overtreatment due to recent BCG vaccination 6. Treat LTBI with isoniazid unless specific evidence of INHresistance is uncovered Interferon γ tests o o o o MTB specific antigens: Genes s in region of difference (RD1) on MTB genome Culture filtrate protein 10 (CFP10) Early secretory antigen target 6 (ESAT6) Identifies LTBI &/or disease Does not cross react with BGC vaccine or most other mycobacteria Requires: single medical visit blood collection laboratory equipment and personnel o Results in hrs 12

13 Commercial Tests QuantiFERONTB Gold Company: Cellestis, Australia US FDA approved Available in some areas of US InTube improvement o Method: Whole blood Incubated with MTB antigens (ESAT6 6 & CFP10) TCells produce INF γ Supernate removed INF γ measured by ELISA reader TSpot. Spot.TB or ELISPOT Company: Oxford Immunotec, UK FDA reviewing Available in Europe & Canada o Method: Tcells Incubated with MTB antigens (ESAT6 6 & CFP10) TCells produce INF γ IFN γ binds to antibody in wells Spots develop and are counted manually or by reader Comparison of Tuberculin Skin Test and Interferon ٢ Release Assays Antigens studied Crossreactivity reactivity with BCG Crossreactivity reactivity with NTM Estimated sensitivity, TB in immunocompetent adults Estimated specificity, TB in immunocompetent adults Distinguish between TB infection and TB disease Boosting Patient visits required Tuberculin Skin Test Many PPD Yes Yes 7590% 7095% No Yes Two IFN ٢ Release Assay ESAT6, CFP10 Unlikely Less Likely 7595% 90100% No No One 13

14 Sensitivity and Specificity QuantiFERONTB Gold Sensitivity* (95%CI) Mori ( 04)( 04) 89 (8294) 05) 85 (7294) 05) 80 (6790) 05) 75 (6485) Ravn ( 05)( Kang ( 05)( Pai ( 05)( Specificity+ (95%CI) Mori ( 04)( 98 (9599) Ravn ( 05)( 97 (87100) Kang ( 05)( 96 (9099) Goletti ( 05)( 90 (6899) TSpot. Spot.TB or ELISPOT Sensitivity* (95%CI) Lalvni ( 01a)( 96 (8599) Lalvni ( 01b)( 80 (6690) Pathan ( 01)( 92 (7499) Chapman ( 02)( 92 (8198) Liebeschuetz( 04) 83 (7589) Meier ( 05)( 97 (90100) Specificity+ (95%CI) Lalvni ( 01a)( 91 (8098) Pathan ( 01)( 100(89100) Meier ( 05)( 92 (62100) *Sensitivity in pts with active TB, Cx = Gold standard +Specificity in healthy low risk patients without TB Pai, Expert Rev Mol Diagn. 6(3): (2006) Interferon γ tests Problems Variable sensitivity (7597%) in active TB disease Specificity reported high (95%) but no gold standard for LTBI and concordance estimates 6090% with TST and Interferon γ tests 14

15 TCELL ASSAYS FOR TUBERCULOSIS IN CHILDREN More data available for TSPOT. T SPOT.TBTB Appear to be more specific for tuberculosis infection, especially in low prevalence conditions Sensitivity is a bigger issue, especially in high prevalence conditions [recent contact] Dynamics of tests are largely unknown Results have been highly variable, and indeterminate results are common with QuantiFERONTB Gold TRANSITIONS IN TUBERCULOSIS Susceptible Exposed Infected *Diseased Sick Diagnosed Treated Cured 15

16 HOW IS TUBERCULOSIS S DIAGNOSED? Adults Mycobacterialbased based diagnosis is positive sputum AFB smear 60% 75% positive sputum culture 90% positive tuberculin skin test 80% [HIV < 50%] Childre ildren positive sputum or gastric AFB smear 10% positive sputum or gastric culture 10% 40% positive tuberculin skin test 50% 80% 16

17 DIAGNOSIS OF TUBERCULOSIS The diagnosis of tuberculosis in children relies on careful and thorough assessment of all the evidence derived from a careful history, clinical examination and relevant investigations, e.g. the tuberculin skin test [TST], chest radiography [CXR] and sputum smear microscopy. Stop TB Partnership Childhood TB Subgroup DIAGNOSIS OF TUBERCULOSIS Even in developed countries, the gold standard for the diagnosis of tuberculosis in children is the triad of: 1. a positive TST 2. an abnormal CXR and/or physical exam 3. a history of recent contact to an infectious adult case of TB 17

18 CLINICAL SCORING SYSTEMS FOR TUBERCULOSIS IN CHILDREN 17 scoring systems published since 1950 point systems (5) diagnostic algorithms (2) diagnostic classifications (5) combinations (5) 7 systems evaluated [none in HIV+ children] 5 prospective, 2 retrospective, none controlled OBTAINING CULTURE AND AFB SMEAR SAMPLES FROM CHILDREN Traditional method is gastric aspiration, performed as an inpatient t on 3 consecutive mornings expensive, invasive Bronchioalveolar lavage has no advantage Nasopharyngeal aspiration few studies Other sites yields usually 0% 25% culture positive, <10% smear positive 18

19 INDUCED SPUTUM COLLECTION N IN CHILDREN Zar et al. Lancet 2005; 365: 130. Can be done inpatient or outpatient Infection control precautions important Salbutamol, followed by 15 minutes of 5% hypertonic saline solution Sputum obtained via suction with a nasopharyngeal catheter Yield: 30% to 40% culture positive INTERPRETING CHILDREN S S CHEST RADIOGRAPHS FOR TB Rarely available in highest prevalence areas Marked inter and intra observer variability Reliable in expert hands and in the presence of suspicious symptoms Commonest picture is persistent opacification together with enlarged hilar or subcarinal lymph nodes [though nodes not always discernable] The xray x is usually sicker than the patient! 19

20 CHEST RADIOGRAPH TECHNIQUE FOR CHILDREN Check for three important features 1. Rotation can make mediastinum be wider 2. Inspiration when inadequate, can cause mass effect of mediastinum, hilum 3. Penetration difficult to interpret if xray is too white or too black 20

21 21

22 22

23 TUBERCULOSIS IN HIVINFECTED INFECTED CHILDREN Clinical and Radiographic Presentation in children with prese eserved d immunocompetence, ce, presenp resentation tion isi indistinguishable from HIVuninfec uninfected d children most common on symptoms s remain malnutri nutrition, tion, fever, night sweats, s, lymphadenopath mphadenopathy and cough extrapulmonary disease (meningitis s and a tuberculo uloma, a, abdominal) is i more common on TB meningiti tis s has the same clinical cal and a CSF findings ngs as in HIV uninfected children excee xcept that intra tracerebral mass lesions s are more common on chest t radiograph findings s are typical, but more extensiv tensive e and a broader diffe fferential ential diagnosis 23

24 TUBERCULOSIS IN HIVINFECTED INFECTED CHILDREN Diagnostic Considerations Diagnosis of TB remains a problem, even in the best of centers broader differential diagnosis Culture yields y are about the same s for HIVinfected and HIVuninfected children when controlled for extent of disease Tuberculin skin test is useful u in immunocompetent HIVinfected children but usefulness u diminished with worsening immunocompromise Interferon release assays no data for HIVinfected children TUBERCULOSIS IN HIVINFECTED INFECTED CHILDREN BCG Disease Hesseling et al. Clin Infect Dis 2006; 42:548 BCG disease diagnosed in 25 children over 3 years 17/25 were HIVinfected; 2 had other immunocompromise Overall, 22 (88%) had local disease, 8 (32%) had distant or disseminated disease; 5 (20%) had d both Of HIVinfected children, 6 (35%) had disseminated disease Mortality y rate for disseminated disease 75% 24

25 IRIS AND MYCOBACTERIA Socalled paradoxical reactions occur in 2% to 23% of HIVnegative adult patients receiving treatment for tuberculosis Most common features are fever and lymph l node enlargement, though respiratory failure anda neurologic deterioration also occur Median time is 4090 days after TB treatment is started Abnormality is at the orig iginalinal site of infection ion in 75% of cases, at a new location in 25% Mechanism: increased tumor necrosis factor IRIS IN CHILDREN Puthanakit t et e al. Pediatr Infect Dis J 2006; ; 25:532 32/153 3 (21%) HIVinfected Thai children developed IRIS after starting ting HAART 14/32 (44%) ) episodes associa sociated with h mycobacteria [3TB, 22 BCG, 7MAC Complex, 2other other] In 11 of o 14 patients, the mycobacteri cobacterial l infec fections had not been diagnosed priorp to startis ting HAART 7 varicellav ricellazo zoster,, 7HSV, 3 Cryptoco yptococcus, cus, 1 Guillain lainba Barre Children who o developed IRIS had d significantly lower r baseline CD4 lympho mphocyte counts 25

26 NEEDED IMPROVEMENTS IN DIAGNOSIS OF CHILDHOOD TUBERCULOSIS Further characterize the Tcell T assays Refine and validate clinical scoring systems Study all tests in HIVinfected children Make chest radiography more readily available much more important role for children than for adults Pediatricians must advocate for resources MOST IMPORTANT Design TB control programs to link children with likely source cases CONTACT TRACING!!! 26

The Origin of Swine Flu

The Origin of Swine Flu How the Heck Do You Diagnose Tuberculosis in Children, Anyway? Jeffrey R. Starke, M.D. Professor and Vice Chairman of Pediatrics Baylor College of Medicine Houston, Texas USA The Origin of Swine Flu MAIN

More information

TB Intensive San Antonio, Texas

TB Intensive San Antonio, Texas TB Intensive San Antonio, Texas August 2-5, 2011 Pediatric TB Jeffrey Starke, MD August 5, 2011 Jeffrey Starke, MD has the following disclosures to make: Is on a data safety monitoring board for Hoffman

More information

TB Nurse Case Management

TB Nurse Case Management TB Nurse Case Management San Antonio, Texas March 2-4, 2011 Pediatric TB Andrea T. Cruz, MD, MPH March 2, 2011 Andrea Cruz, MD, MPH has the following disclosures to make: No conflict of interests No relevant

More information

CHILDHOOD TUBERCULOSIS: NEW WRINKLES IN AN OLD DISEASE [FOR THE NON-TB EXPERT]

CHILDHOOD TUBERCULOSIS: NEW WRINKLES IN AN OLD DISEASE [FOR THE NON-TB EXPERT] CHILDHOOD TUBERCULOSIS: NEW WRINKLES IN AN OLD DISEASE [FOR THE NON-TB EXPERT] QUESTION: : Which children in the United States should get a tuberculin skin test? Do questionnaires really work? Jeffrey

More information

TB Prevention Who and How to Screen

TB Prevention Who and How to Screen TB Prevention Who and How to Screen 4.8.07. IUATLD 1st Asia Pacific Region Conference 2007 Dr Cynthia Chee Dept of Respiratory Medicine / TB Control Unit Tan Tock Seng Hospital, Singapore Cycle of Infection

More information

Diagnosis of tuberculosis in children

Diagnosis of tuberculosis in children Diagnosis of tuberculosis in children H Simon Schaaf Desmond Tutu TB Centre Department of Paediatrics and Child Health, Stellenbosch University, and Tygerberg Children s Hospital (TCH) Estimated TB incidence

More information

New Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents

New Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents New Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents Jeffrey R. Starke, M.D. Professor of Pediatrics Baylor College of Medicine [With great thanks to Andrea

More information

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011 TB Nurse Case Management Davenport, Iowa September 27 28, 2011 Pediatric TB Lisa Armitige, MD, PhD September 28, 2011 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of interest.

More information

Tuberculosis Intensive

Tuberculosis Intensive Tuberculosis Intensive San Antonio, Texas April 3 6, 2012 Childhood Tuberculosis Kim Smith, MD, MPH April 6, 2012 Kim Smith, MD, MPH has the following disclosures to make: No conflict of interests No relevant

More information

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

TB Nurse Case Management San Antonio, Texas July 18 20, 2012 TB Nurse Case Management San Antonio, Texas July 18 20, 2012 Pediatric TB Kim Smith, MD, MPH July 19, 2012 Kim Smith, MD, MPH has the following disclosures to make: No conflict of interests No relevant

More information

Childhood Tuberculosis Some Basic Issues. Jeffrey R. Starke, M.D. Baylor College of Medicine

Childhood Tuberculosis Some Basic Issues. Jeffrey R. Starke, M.D. Baylor College of Medicine Childhood Tuberculosis Some Basic Issues Jeffrey R. Starke, M.D. Baylor College of Medicine TUBERCULOSIS IS A SOCIAL DISEASE WITH MEDICAL IMPLICATIONS THE GREAT PARADOX OF TUBERCULOSIS A CAUTIONARY TALE

More information

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Randy Culpepper, MD, MPH Deputy Heath Officer/Medical Director Frederick County Health Department March 16, 2016 2 No

More information

TB Intensive Houston, Texas. Childhood Tuberculosis Kim Connelly Smith. November 12, 2009

TB Intensive Houston, Texas. Childhood Tuberculosis Kim Connelly Smith. November 12, 2009 TB Intensive Houston, Texas November 10-12, 12 2009 Childhood Tuberculosis Kim Connelly Smith MD, MPH November 12, 2009 Childhood Tuberculosis Kim Connelly Smith MD, MPH November 12, 2009 1 OUTLINE Stages

More information

TB Intensive Tyler, Texas December 2-4, 2008

TB Intensive Tyler, Texas December 2-4, 2008 TB Intensive Tyler, Texas December 2-4, 2008 Interferon Gamma Releasing Assays: Diagnosing TB in the 21 st Century Peter Barnes, MD December 2, 2008 TOPICS Use of interferon-gamma release assays (IGRAs)

More information

Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017

Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017 Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD has the following disclosures

More information

TB Nurse Case Management San Antonio, Texas March 7 9, Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012

TB Nurse Case Management San Antonio, Texas March 7 9, Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012 TB Nurse Case Management San Antonio, Texas March 7 9, 2012 Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012 Kim Connelly Smith, MD, MPH has the following disclosures to make: No conflict of interests

More information

Diagnosis and Medical Management of Latent TB Infection

Diagnosis and Medical Management of Latent TB Infection Diagnosis and Medical Management of Latent TB Infection Marsha Majors, RN September 7, 2017 TB Contact Investigation 101 September 6 7, 2017 Little Rock, AR EXCELLENCE EXPERTISE INNOVATION Marsha Majors,

More information

TB & HIV CO-INFECTION IN CHILDREN. Reené Naidoo Paediatric Infectious Diseases Broadreach Healthcare 19 April 2012

TB & HIV CO-INFECTION IN CHILDREN. Reené Naidoo Paediatric Infectious Diseases Broadreach Healthcare 19 April 2012 TB & HIV CO-INFECTION IN CHILDREN Reené Naidoo Paediatric Infectious Diseases Broadreach Healthcare 19 April 2012 Introduction TB & HIV are two of the leading causes of morbidity & mortality in children

More information

Disclosures. Current Issues and Controversies in Child and Adolescent Tuberculosis 02/24/2016. NSTC 2016 Annual Meeting

Disclosures. Current Issues and Controversies in Child and Adolescent Tuberculosis 02/24/2016. NSTC 2016 Annual Meeting Current Issues and Controversies in Child and Adolescent Tuberculosis Jeffrey R. Starke, M.D. Professor of Pediatrics Baylor College of Medicine [With great thanks to Andrea Cruz, M.D.] Disclosures Dr.

More information

Approaches to LTBI Diagnosis

Approaches to LTBI Diagnosis Approaches to LTBI Diagnosis Focus on LTBI October 8 th, 2018 Michelle Haas, M.D. Associate Director Denver Metro Tuberculosis Program Denver Public Health DISCLOSURES I have no disclosures or conflicts

More information

Tuberculosis Tools: A Clinical Update

Tuberculosis Tools: A Clinical Update Tuberculosis Tools: A Clinical Update CAPA Conference 2014 JoAnn Deasy, PA-C. MPH, DFAAPA jadeasy@sbcglobal.net Adjunct Faculty Touro PA Program Learning Objectives Outline the pathogenesis of active pulmonary

More information

Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010

Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010 Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010 What is Latent TB Infection (LTBI)? Traci Hadley, RN October 5, 2010 LTBI or TB Disease? Presented by : Traci Hadley, RN

More information

Gary Reubenson 16 October 2012 PAEDIATRIC TUBERCULOSIS: AN OVERVIEW IN 40 MINUTES!!

Gary Reubenson 16 October 2012 PAEDIATRIC TUBERCULOSIS: AN OVERVIEW IN 40 MINUTES!! Gary Reubenson 16 October 2012 PAEDIATRIC TUBERCULOSIS: AN OVERVIEW IN 40 MINUTES!! DECLARATION No relevant conflicts of interest to declare OVERVIEW Burden of disease & epidemiology Pathogenesis (not

More information

Barbara J Seaworth MD Medical Director, Heartland National TB Center Professor, Internal Medicine and Infectious Disease UT Health Northeast

Barbara J Seaworth MD Medical Director, Heartland National TB Center Professor, Internal Medicine and Infectious Disease UT Health Northeast Practical Aspects for Using the Interferon Gamma Release Assay (IGRA) Test Live Webinar July 14, 2017 Barbara J Seaworth MD Medical Director, Heartland National TB Center Professor, Internal Medicine and

More information

Contact Follow-Up and Treatment of LTBI in Households of Infectious Cases in Pakistan

Contact Follow-Up and Treatment of LTBI in Households of Infectious Cases in Pakistan Contact Follow-Up and Treatment of LTBI in Households of Infectious Cases in Pakistan 17 th Annual Conference, The Union-North American Region, Vancouver, Canada. 28 February 2013 Farhana Amanullah Director

More information

Fundamentals of Tuberculosis (TB)

Fundamentals of Tuberculosis (TB) TB in the United States Fundamentals of Tuberculosis (TB) From 1953 to 1984, reported cases decreased by approximately 5.6% each year From 1985 to 1992, reported cases increased by 20% 25,313 cases reported

More information

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Diagnosis of active TB Screening

More information

Targeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease

Targeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease Self-Study Study Modules on Tuberculosis Targeted Testing and the Diagnosis of Latent Tuberculosis Infection and Tuberculosis Disease 1 Module 3: Objectives At completion of this module, learners will

More information

Making the Diagnosis of Tuberculosis

Making the Diagnosis of Tuberculosis Making the Diagnosis of Tuberculosis Alfred Lardizabal, MD NJMS Global Tuberculosis Institute Testing for TB Infection Targeted Testing: Key Points Test only if plan for ensuring treatment De-emphasizes

More information

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis What the Primary Physician Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Microbiology Epidemiology Common disease presentations Diagnosis of active

More information

Contracts Carla Chee, MHS May 8, 2012

Contracts Carla Chee, MHS May 8, 2012 Moving Past the Basics of Tuberculosis Phoenix, Arizona May 8-10, 2012 Contracts Carla Chee, MHS May 8, 2012 Carla Chee, MHS has the following disclosures to make: No conflict of interests No relevant

More information

TB Intensive San Antonio, Texas August 7-10, 2012

TB Intensive San Antonio, Texas August 7-10, 2012 TB Intensive San Antonio, Texas August 7-10, 2012 An Introduction to Childhood Tuberculosis Kim Smith, MD, MPH August 10, 2012 Kim Smith, MD, MPH has the following disclosures to make: No conflict of interests

More information

Dr Francis Ogaro MTRH ELDORET

Dr Francis Ogaro MTRH ELDORET Dr Francis Ogaro MTRH ELDORET TB in children often severe, disseminated and can progress rapidly and with poor outcome TB diagnosis in children has relied on clinical, imaging, microscopy and TST findings.

More information

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB What the Primary Physician Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Common disease presentations Diagnosis of active TB Screening

More information

Diagnosis of tuberculosis in children H Simon Schaaf

Diagnosis of tuberculosis in children H Simon Schaaf Diagnosis of tuberculosis in children H Simon Schaaf Desmond Tutu TB Centre Department of Paediatrics and Child Health, Stellenbosch University, and Tygerberg Children s Hospital (TCH) Estimated TB incidence

More information

TB Intensive Houston, Texas October 15-17, 2013

TB Intensive Houston, Texas October 15-17, 2013 TB Intensive Houston, Texas October 15-17, 2013 Interferon Gamma Release Assays (IGRA s) Lisa Armitige, MD, PhD October 16, 2013 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict

More information

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection? Those oral antibiotics are just not working! Inpatient Standards of Care & Discharge Planning S/He s in the Hospital: Now What Do I Do? Dana G. Kissner, MD TB Intensive Workshop, Lansing, MI 2012 Objectives:

More information

TB Intensive San Antonio, Texas November 11 14, 2014

TB Intensive San Antonio, Texas November 11 14, 2014 TB Intensive San Antonio, Texas November 11 14, 2014 Interferon Gamma Release Assays Lisa Armitige, MD, PhD November 12, 2014 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of

More information

Communicable Disease Control Manual Chapter 4: Tuberculosis

Communicable Disease Control Manual Chapter 4: Tuberculosis Provincial TB Services 655 West 12th Avenue Vancouver, BC V5Z 4R4 www.bccdc.ca Communicable Disease Control Manual Definitions Page 1 2.0 DEFINITIONS Many of the definitions that follow are taken from

More information

Management of Pediatric Tuberculosis in New Jersey

Management of Pediatric Tuberculosis in New Jersey Management of Pediatric Tuberculosis in New Jersey Helen Aguila, MD NJMS Global TB Institute December 15, 2011 This presentation is in part adapted from Pediatric Tuberculosis by Ann Loeffler, MD : Francis

More information

Let s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year

Let s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year Madhukar Pai, MD, PhD Author and Series Editor Camilla Rodrigues, MD co-author Abstract Most individuals who get exposed

More information

CHAPTER 3: DEFINITION OF TERMS

CHAPTER 3: DEFINITION OF TERMS CHAPTER 3: DEFINITION OF TERMS NOTE: TB bacteria is used in place of Mycobacterium tuberculosis and Mycobacterium tuberculosis complex in most of the definitions presented here. 3.1 Acid-fast bacteria

More information

Tuberculin Skin Testing

Tuberculin Skin Testing Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010 Testing to TB Infection Using the TST Presented by Debra Howenstine, MD for Debbie Onofre, RN October 5, 2010 Tuberculin

More information

DIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE

DIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE DIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE Annie Kizilbash MD, MPH Assistant Professor University of Texas Health Science Center Staff Physician, Texas Center for Infectious Diseases TB Nurse Case

More information

Tuberculosis Update. Topics to be Addressed

Tuberculosis Update. Topics to be Addressed Tuberculosis Update Robert M. Jasmer, M.D. University of California, San Francisco TB Control Section, San Francisco Department of Public Health Topics to be Addressed TB in the USA Screening recommendations

More information

TUBERCULOSIS. Pathogenesis and Transmission

TUBERCULOSIS. Pathogenesis and Transmission TUBERCULOSIS Pathogenesis and Transmission TUBERCULOSIS Pathogenesis and Transmission Infection to Disease Diagnostic & Isolation Updates Treatment Updates Pathogenesis Droplet nuclei of 5µm or less are

More information

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

TB Nurse Case Management San Antonio, Texas July 18 20, 2012 TB Nurse Case Management San Antonio, Texas July 18 20, 2012 IGRA s and Their Use in TB Nurse NCM Lisa Armitige, MD, PhD July 18, 2012 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict

More information

Jeffrey R. Starke, M.D. has the following disclosures to make:

Jeffrey R. Starke, M.D. has the following disclosures to make: AAP 2018 Red Book Tuberculosis: IGRAs and Treatment of TB Infection Jeffrey R. Starke, M.D. May 31, 2018 AAP 2018 Red Book Childhood Tuberculosis: IGRAs and Treatment of TB Infection May 31, 2018 WEBINAR

More information

TB Intensive San Antonio, Texas May 7-10, 2013

TB Intensive San Antonio, Texas May 7-10, 2013 TB Intensive San Antonio, Texas May 7-10, 2013 TB in the HIV Patient Lisa Armitige, MD, PhD May 09, 2013 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of interests No relevant

More information

PEDIATRIC TUBERCULOSIS. Objectives. Children are not just small adults. Pediatric Tuberculosis 1

PEDIATRIC TUBERCULOSIS. Objectives. Children are not just small adults. Pediatric Tuberculosis 1 PEDIATRIC TUBERCULOSIS Ann M. Loeffler, M.D. Faculty Consultant Curry International Tuberculosis Center Objectives At the end of this session, participants will be able to describe: how pediatric patients

More information

PEDIATRIC TUBERCULOSIS

PEDIATRIC TUBERCULOSIS PEDIATRIC TUBERCULOSIS Ann M. Loeffler, M.D. Faculty Consultant Curry International Tuberculosis Center Objectives At the end of this session, participants will be able to describe: how pediatric patients

More information

Tuberculosis Intensive

Tuberculosis Intensive Tuberculosis Intensive San Antonio, Texas April 3 6, 2012 TB in the HIV Patient Lisa Armitige, MD, PhD April 6, 2012 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of interests

More information

Diagnosis Latent Tuberculosis. Disclosures. Case

Diagnosis Latent Tuberculosis. Disclosures. Case Diagnosis Latent Tuberculosis Neha Shah MD MPH Field Medical Officer Tuberculosis Control Branch California Department of Public Health Centers for Disease Control and Prevention September 2016 1 Disclosures

More information

Evaluation and Treatment of TB Contacts Tyler, Texas April 11, 2014

Evaluation and Treatment of TB Contacts Tyler, Texas April 11, 2014 Evaluation and Treatment of TB Contacts Tyler, Texas April 11, 2014 Interferon Gamma Release Assays: Understanding the Test David Griffith, BA, MD April 11, 2014 David Griffith, BA, MD has the following

More information

Using Interferon Gamma Release Assays for Diagnosis of TB Infection

Using Interferon Gamma Release Assays for Diagnosis of TB Infection Learning Objectives Using Interferon Gamma Release Assays for Diagnosis of TB Infection 1. Describe available Interferon Gamma Release Assay tests for TB infection and how they work. 2. Understand interpretation

More information

Tuberculosis in Children and Adolescents 2017

Tuberculosis in Children and Adolescents 2017 Tuberculosis in Children and Adolescents 2017 George D. McSherry, MD Division of Infectious Diseases Penn State Children s Hospital and Pediatric Section Northeastern Regional Training and Medical Consultation

More information

At the end of this session, participants will be able to:

At the end of this session, participants will be able to: Advanced Concepts in Pediatric Tuberculosis: Infection Control, Source Case and Contact Investigation Ana M. Alvarez, M.D. Associate Professor Division of Pediatric Infectious Diseases and Immunology University

More information

INDEX CASE INFORMATION

INDEX CASE INFORMATION Instructions for Completing the MDH Tuberculosis Contact Investigation Report Form Please provide as much information as possible. Each field represents information that is important to the contact investigation.

More information

TB Intensive San Antonio, Texas. TB/HIV Co-Infection. Lisa Armitige, MD, PhD has the following disclosures to make:

TB Intensive San Antonio, Texas. TB/HIV Co-Infection. Lisa Armitige, MD, PhD has the following disclosures to make: TB Intensive San Antonio, Texas August 2-5, 2011 TB/HIV Co-Infection Lisa Armitige, MD, PhD August 4, 2011 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of interests No relevant

More information

Diagnosing Tuberculosis in Pediatric Patients Kim Connelly Smith, MD, MPH November 13, 2008

Diagnosing Tuberculosis in Pediatric Patients Kim Connelly Smith, MD, MPH November 13, 2008 Tuberculosis Updates for Clinicians San Antonio, Texas November 13, 2008 Diagnosing Tuberculosis in Pediatric Patients Kim Connelly Smith, MD, MPH November 13, 2008 Childhood Tuberculosis Kim Connelly

More information

Evaluation of Mycobacterium tuberculosis specific T cell response to ESAT-6 and PPD antigen with ELISPOT assay

Evaluation of Mycobacterium tuberculosis specific T cell response to ESAT-6 and PPD antigen with ELISPOT assay In the name of God Evaluation of Mycobacterium tuberculosis specific T cell response to ESAT-6 and PPD antigen with ELISPOT assay presented by: M. Taheri Symptoms of TB Cough for more than two week Bloody

More information

Self-Study Modules on Tuberculosis

Self-Study Modules on Tuberculosis Self-Study Modules on Tuberculosis Targe te d Te s ting and the Diagnosis of Latent Tuberculosis Infection and Tuberculosis Disease U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control

More information

ORIGINAL ARTICLE. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients

ORIGINAL ARTICLE. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients ERJ Express. Published on July 25, 2007 as doi: 10.1183/09031936.00040007 ORIGINAL ARTICLE Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients Yoshihiro Kobashi, Keiji Mouri, Yasushi

More information

Latent TB, TB and the Role of the Health Department

Latent TB, TB and the Role of the Health Department Latent TB, TB and the Role of the Health Department Elaine Darnall, RN, BSN, CIC TB Nurse Consultant Illinois Dept of Public Health March 21, 2018 Elaine Darnall has disclosed that there is no actual or

More information

Northwestern Polytechnic University

Northwestern Polytechnic University Clinical Tuberculosis Assessment by Health Care Provider Clinicians should review and verify the information in the Tuberculosis (TB) Screening Questionnaire (attached). Persons answering YES to any questions

More information

TB Intensive Houston, Texas October 15-17, 2013

TB Intensive Houston, Texas October 15-17, 2013 TB Intensive Houston, Texas October 15-17, 2013 Tuberculosis in Children Kim Connelly Smith, MD, MPH October 16, 2013 Kim Connelly Smith, MD, MPH has the following disclosures to make: No conflict of interests

More information

Pediatric TB Intensive Houston, Texas

Pediatric TB Intensive Houston, Texas Pediatric TB Intensive Houston, Texas November 13, 2009 Treatment of Pediatric TB Jeffrey R. Starke, M.D. November 13, 2009 MANAGEMENT OF CHILDHOOD TUBERCULOSIS Jeffrey R. Starke, M.D. Professor of Pediatrics

More information

Contact Investigation and Prevention in the USA

Contact Investigation and Prevention in the USA Contact Investigation and Prevention in the USA George D. McSherry, MD Division of Infectious Disease Penn State Children s Hospital Pediatric Section TB Center of Excellence Rutgers Global Tuberculosis

More information

Errors in Dx and Rx of TB

Errors in Dx and Rx of TB Errors in Dx and Rx of TB David Schlossberg, MD, FACP Professor of Medicine Temple University School of Medicine Medical Director, TB Control Program Philadelphia Department of Public Health TB Still a

More information

TB in the Patient with HIV

TB in the Patient with HIV TB in the Patient with HIV Lisa Y. Armitige, MD, PhD May 11, 2017 TB Intensive May 9 12, 2017 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD, has the following disclosures to

More information

Diagnostic challenges of active childhood TB in Tanzania. Michala Vaaben Rose, MD, Ph.D Department of Infectious Diseases, Hvidovre

Diagnostic challenges of active childhood TB in Tanzania. Michala Vaaben Rose, MD, Ph.D Department of Infectious Diseases, Hvidovre Diagnostic challenges of active childhood TB in Tanzania Michala Vaaben Rose, MD, Ph.D Department of Infectious Diseases, Hvidovre 1 Diagnosis of Childhood Tuberculosis Muheza hospital, TZ Hilleroedhospital.dk

More information

Research in Tuberculosis: Translation into Practice

Research in Tuberculosis: Translation into Practice Case History Research in Tuberculosis: Translation into Practice This is a 6-year6 year-old Bosnian male, who presented to ER with one-week history of fever and occasional vomiting. No cough, difficulty

More information

Diagnosis of tuberculosis

Diagnosis of tuberculosis Diagnosis of tuberculosis Madhukar Pai, MD, PhD Assistant Professor, Epidemiology McGill University, Montreal, Canada madhukar.pai@mcgill.ca Global TB Case Detection A major concern 2.6 million new smear

More information

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection (LTBI) Lloyd Friedman, M.D. Milford Hospital Yale University

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection (LTBI) Lloyd Friedman, M.D. Milford Hospital Yale University Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection (LTBI) Lloyd Friedman, M.D. Milford Hospital Yale University Tuberculosis Estimates USA World Infection 15,000,000 2,000,000,000

More information

PREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal

PREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal PREVENTION OF TUBERCULOSIS Dr Amitesh Aggarwal 25 to 50 % of persons exposed to intimate contact with active PTB - latent infection with TB. Exposure to index case for 12 hours - high risk of infection.

More information

Core Curriculum on Tuberculosis: What the Clinician Should Know

Core Curriculum on Tuberculosis: What the Clinician Should Know Core Curriculum on Tuberculosis: What the Clinician Should Know Sixth Edition 2013 National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination 1 Chapters

More information

TB: A Supplement to GP CLINICS

TB: A Supplement to GP CLINICS TB: A Supplement to GP CLINICS Chapter 10: Childhood Tuberculosis: Q&A For Primary Care Physicians Author: Madhukar Pai, MD, PhD Author and Series Editor What is Childhood TB and who is at risk? India

More information

Tuberculosis Populations at Risk

Tuberculosis Populations at Risk Tuberculosis Populations at Risk One-third of the world is infected with TB, an average of one new infection per second Two million people died from tuberculosis in 2010, 1 every 20 seconds TB is the leading

More information

2. Methods of Tuberculosis Screening

2. Methods of Tuberculosis Screening 2. Methods of Tuberculosis Screening Diagnosis of active or latent TB involves a number of tests. There is no gold standard for determining whether a person is infected with M. tuberculosis but in practice

More information

New Tuberculosis Guidelines. Jason Stout, MD, MHS

New Tuberculosis Guidelines. Jason Stout, MD, MHS New Tuberculosis Guidelines Jason Stout, MD, MHS Two New Sets of Guidelines Treatment of Drug-Susceptible Tuberculosis Clinical Infectious Diseases 2016; 63(7): e147-e195 Diagnosis of Tuberculosis in Adults

More information

Screening for Tuberculosis Infection. Harlingen, TX. Linda Dooley, MD has the following disclosures to make:

Screening for Tuberculosis Infection. Harlingen, TX. Linda Dooley, MD has the following disclosures to make: TB Infection Diagnosis Recommendations Talk Developed by Lisa Y. Armitige, MD, PhD Medical Consultant, Heartland National TB Center Associate Professor Internal Medicine/Pediatrics/Infectious Disease UT

More information

TB Skin Test Practicum Houston, Texas Region 6/5 South September 23, 2014

TB Skin Test Practicum Houston, Texas Region 6/5 South September 23, 2014 TB Skin Test Practicum Houston, Texas Region 6/5 South September 23, 2014 Catalina Navarro, BSN, RN has the following disclosures to make: No conflict of interests No relevant financial relationships with

More information

Testing for TB. Bart Van Berckelaer Territory Manager Benelux. Subtitle

Testing for TB. Bart Van Berckelaer Territory Manager Benelux. Subtitle Testing for TB Bart Van Berckelaer Territory Manager Benelux Subtitle Agenda TB infection pathway TB immunisation Testing options Pre lab considerations of the whole blood ELISA test The T-SPOT.TB test

More information

Diagnosis & Medical Case Management of TB Disease. Lisa Armitige, MD, PhD October 22, 2015

Diagnosis & Medical Case Management of TB Disease. Lisa Armitige, MD, PhD October 22, 2015 Diagnosis & Medical Case Management of TB Disease Lisa Armitige, MD, PhD October 22, 2015 Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS EXCELLENCE

More information

Research Methods for TB Diagnostics. Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012

Research Methods for TB Diagnostics. Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012 Research Methods for TB Diagnostics Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012 Overview Why do we need good TB diagnostics? What works? What doesn t work? How

More information

Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients

Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients Eur Respir J 2007; 30: 945 950 DOI: 10.1183/09031936.00040007 CopyrightßERS Journals Ltd 2007 Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients Y. Kobashi, K. Mouri, Y. Obase,

More information

Pediatric Drug-Resistant TB in China

Pediatric Drug-Resistant TB in China Pediatric Drug-Resistant TB in China Shuihua Lu,Tao Li Shanghai Public Health Clinical Center Jan.18,2013 A MDR-TB CASE A four and a half years old boy, spent 4 yeas of his life in hospital. His childhood

More information

Didactic Series. Latent TB Infection in HIV Infection

Didactic Series. Latent TB Infection in HIV Infection Didactic Series Latent TB Infection in HIV Infection Jacqueline Peterson Tulsky, MD UCSF Positive Health Program at SFGH Medical Director, SF and North Coast AETC March 13, 2014 ACCREDITATION STATEMENT:

More information

The Diagnosis of Active TB. Deborah McMahan, MD TB Intensive September 28, 2017

The Diagnosis of Active TB. Deborah McMahan, MD TB Intensive September 28, 2017 The Diagnosis of Active TB Deborah McMahan, MD TB Intensive September 28, 2017 Agenda Epidemiology Big picture Conditions that Should Make You Suspicious Which test? Eeenie meenie miny mo Radiographic

More information

Immune Reconstitution Inflammatory Syndrome. Dr. Lesego Mawela

Immune Reconstitution Inflammatory Syndrome. Dr. Lesego Mawela Immune Reconstitution Inflammatory Syndrome Dr. Lesego Mawela TOPICS FOR DISCUSSION IRIS Case Epidermiology Pathogenesis of IRIS Risk factors for IRIS Epidemiology of IRIS Health system burden of IRIS

More information

TB Update: March 2012

TB Update: March 2012 TB Update: March 2012 David Schlossberg, MD, FACP Medical Director, TB Control Program Philadelphia Department of Public Health 1 TB Update: March 2012 IGRAs vs TST LTBI A New Regimen NAATs What is Their

More information

결핵노출접촉자감염관리 서울아산병원감염내과 김성한

결핵노출접촉자감염관리 서울아산병원감염내과 김성한 결핵노출접촉자감염관리 서울아산병원감염내과 김성한 TB incidence (2012) TB incidence South Korea 108 China 73 Taiwan 68 Portucal 26 Japan 19 Spain 14 US 3.6 * unit- per 100,000 population Adapted from WHO Adapted from WHO Emerg

More information

Pediatric TB Intensive Houston, Texas October 14, 2013

Pediatric TB Intensive Houston, Texas October 14, 2013 Pediatric TB Intensive Houston, Texas October 14, 2013 Diagnosis and Management of Tuberculosis in Adolescents Andrea T. Cruz, MD, MPH Sections of Infectious Diseases & Emergency Medicine October 14, 2013

More information

Epidemiology and diagnosis of MDR-TB in children H Simon Schaaf

Epidemiology and diagnosis of MDR-TB in children H Simon Schaaf Epidemiology and diagnosis of MDR-TB in children H Simon Schaaf Desmond Tutu TB Centre Department of Paediatrics and Child Health, Stellenbosch University, and Tygerberg Children s Hospital (TCH) Definitions

More information

Pediatric TB Theresa Barton, MD

Pediatric TB Theresa Barton, MD TB Nurse Case Management San Antonio, Texas December 8-10, 2009 Pediatric TB Theresa Barton, MD December 9, 2009 Pediatric Tuberculosis Tess Barton, MD Assistant Professor of Pediatrics UT Southwestern

More information

These recommendations will remain in effect until the national shortage of PPD solution has abated.

These recommendations will remain in effect until the national shortage of PPD solution has abated. Maryland Recommendations Regarding the National Shortage of Purified Protein Derivative (PPD) Solution; Attachment to Health Officer Memorandum National Shortages of Tubersol and Aplisol for TB Skin Testing;

More information

TUBERCULOSIS. Presented By: Public Health Madison & Dane County

TUBERCULOSIS. Presented By: Public Health Madison & Dane County TUBERCULOSIS Presented By: Public Health Madison & Dane County What is Tuberculosis? Tuberculosis, or TB, is a disease caused by a bacteria called Mycobacterium tuberculosis. The bacteria can attack any

More information